Literature DB >> 20412865

The genus Prevotella in cystic fibrosis airways.

Tyler R Field1, Christopher D Sibley, Michael D Parkins, Harvey R Rabin, Michael G Surette.   

Abstract

Airway disease resulting from chronic bacterial colonization and consequential inflammation is the leading cause of morbidity and mortality in patients with Cystic Fibrosis (CF). Although traditionally considered to be due to only a few pathogens, recent re-examination of CF airway microbiology has revealed that polymicrobial communities that include many obligate anaerobes colonize lower airways. The purpose of this study was to examine Prevotella species in CF airways by quantitative culture and phenotypic characterization. Expectorated sputum was transferred to an anaerobic environment immediately following collection and examined by quantitative microbiology using a variety of culture media. Isolates were identified as facultative or obligate anaerobes and the later group was identified by 16S rRNA sequencing. Prevotella spp. represented the majority of isolates. Twelve different species of Prevotella were recovered from 16 patients with three species representing 65% of isolates. Multiple Prevotella species were often isolated from the same sputum sample. These isolates were biochemically characterized using Rapid ID 32A kits (BioMérieux), and for their ability to produce autoinducer-2 and beta-lactamases. Considerable phenotypic variability between isolates of the same species was observed. The quantity and composition of Prevotella species within a patients' airway microbiome varied over time. Our results suggest that the diversity and dynamics of Prevotella in CF airways may contribute to airway disease. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412865     DOI: 10.1016/j.anaerobe.2010.04.002

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  28 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.

Authors:  Lisa A Carmody; Jiangchao Zhao; Patrick D Schloss; Joseph F Petrosino; Susan Murray; Vincent B Young; Jun Z Li; John J LiPuma
Journal:  Ann Am Thorac Soc       Date:  2013-06

3.  Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.

Authors:  Katherine E Price; Amanda A Naimie; Edward F Griffin; Charles Bay; George A O'Toole
Journal:  J Bacteriol       Date:  2015-10-19       Impact factor: 3.490

4.  Airway microbiota across age and disease spectrum in cystic fibrosis.

Authors:  Edith T Zemanick; Brandie D Wagner; Charles E Robertson; Richard C Ahrens; James F Chmiel; John P Clancy; Ronald L Gibson; William T Harris; Geoffrey Kurland; Theresa A Laguna; Susanna A McColley; Karen McCoy; George Retsch-Bogart; Kurtis T Sobush; Pamela L Zeitlin; Mark J Stevens; Frank J Accurso; Scott D Sagel; J Kirk Harris
Journal:  Eur Respir J       Date:  2017-11-16       Impact factor: 16.671

5.  Culture-enriched metagenomic sequencing enables in-depth profiling of the cystic fibrosis lung microbiota.

Authors:  Fiona J Whelan; Barbara Waddell; Saad A Syed; Shahrokh Shekarriz; Harvey R Rabin; Michael D Parkins; Michael G Surette
Journal:  Nat Microbiol       Date:  2020-01-20       Impact factor: 17.745

6.  Analysis of airway microbiota in adults from a Brazilian cystic fibrosis center.

Authors:  Cassiana Costa Ferreira Leite; Flavia Alvim Dutra de Freitas; Mônica de Cássia Firmida; Robson Souza Leão; Rodolpho Mattos Albano; Elizabeth Andrade Marques
Journal:  Braz J Microbiol       Date:  2020-09-17       Impact factor: 2.476

7.  Predominant pathogen competition and core microbiota divergence in chronic airway infection.

Authors:  Geraint B Rogers; Christopher J van der Gast; David J Serisier
Journal:  ISME J       Date:  2014-07-18       Impact factor: 10.302

8.  Age-dependent changes in Porphyromonas gingivalis and Prevotella species/phylotypes in healthy gingiva and inflamed/diseased sub-gingival sites.

Authors:  Mangala A Nadkarni; Kim-Ly Chhour; Gina V Browne; Roy Byun; Ky-Anh Nguyen; Cheryl C Chapple; Nicholas A Jacques; Neil Hunter
Journal:  Clin Oral Investig       Date:  2014-08-09       Impact factor: 3.573

9.  Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis.

Authors:  Laura J Sherrard; Kathryn A Graham; Stef J McGrath; Leanne McIlreavey; Joseph Hatch; Marianne S Muhlebach; Matthew C Wolfgang; Deirdre F Gilpin; J Stuart Elborn; Thamarai Schneiders; Michael M Tunney
Journal:  J Antimicrob Chemother       Date:  2013-05-21       Impact factor: 5.790

10.  The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway.

Authors:  Bojana Mirković; Michelle A Murray; Gillian M Lavelle; Kevin Molloy; Ahmed Abdul Azim; Cedric Gunaratnam; Fiona Healy; Dubhfeasa Slattery; Paul McNally; Joe Hatch; Matthew Wolfgang; Michael M Tunney; Marianne S Muhlebach; Rosaleen Devery; Catherine M Greene; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.